Documentation Centre

 

 

  of 707 Next page

Go to page: of

Screenshot Date Categories Title Author Format
The role of microbiota in nonalcoholic fatty liver disease. Eur J Clin Invest. 2022;52:e13768 October 27, 2022 The role of microbiota in nonalcoholic fatty liver disease. Eur J Clin Invest. 2022;52:e13768 Di Ciaula A, Bonfrate L, Portincasa P Key Publications
Effects of metabolic syndrome on fuel utilization during exercise on middle-aged moderately trained individuals. J Appl Physiol (1985). 2022.doi: 10.1152 October 24, 2022 Effects of metabolic syndrome on fuel utilization during exercise on middle-aged moderately trained individuals. J Appl Physiol (1985). 2022.doi: 10.1152 Álvarez-Jimenez L, Moreno-Cabañas A, Morales-Palomo F, Mora-Rodriguez R Key Publications
Different metabolic phenotypes of obesity and risk of coronary artery calcium progression and incident cardiovascular disease events: the CARDIA study. Arterioscler Thromb Vasc Biol. 2022;42:677-688 August 26, 2022 Different metabolic phenotypes of obesity and risk of coronary artery calcium progression and incident cardiovascular disease events: the CARDIA study. Arterioscler Thromb Vasc Biol. 2022;42:677-688 Gao JW, You S, Liu ZY, Hao QY, Wang JF, Vuitton DA, Zhang SL, Liu PM. Key Publications
The role of metabolic syndrome in sudden cardiac death risk: Recent evidence and future directions. Eur J Clin Invest. 2022;52:e13693 August 15, 2022 The role of metabolic syndrome in sudden cardiac death risk: Recent evidence and future directions. Eur J Clin Invest. 2022;52:e13693 Tirandi A, Carbone F, Montecucco F, Liberale L Key Publications
Metabolic syndrome severity score and the progression of CKD. Eur J Clin Invest. 2022;52:e13646 August 01, 2022 Metabolic syndrome severity score and the progression of CKD. Eur J Clin Invest. 2022;52:e13646 Wu M, Shu Y, Wang L, Song L, Chen S, Liu Y, Bi J, Li D, Yang Y, Hu Y, Wang Y, Wu S, Tian Y Key Publications
Risk classification for metabolic syndrome and the incidence of cardiovascular disease in Japan with low prevalence of obesity: a pooled analysis of 10 prospective cohort studies. J Am Heart Assoc. 2021;10:e020760 July 06, 2022 Risk classification for metabolic syndrome and the incidence of cardiovascular disease in Japan with low prevalence of obesity: a pooled analysis of 10 prospective cohort studies. J Am Heart Assoc. 2021;10:e020760 Iso H, Cui R, Takamoto I, Kiyama M, Saito I, Okamura T, Miyamoto Y, Higashiyama A, Kiyohara Y, Ninomiya T, Yamada M, Nakagawa H, Sakurai M, Shimabukuro M, Higa M, Shimamoto K, Saito S, Daimon M, Kayama T, Noda M, Ito S, Yokote K, Ito C, Nakao K, Yamauchi Key Publications
Metabolic implications of pancreatic fat accumulation. Nat Rev Endocrinol. 2022;18:43-54. July 01, 2022 Metabolic implications of pancreatic fat accumulation. Nat Rev Endocrinol. 2022;18:43-54. Wagner R, Eckstein SS, Yamazaki H, Gerst F, Machann J, Jaghutriz BA, Schürmann A, Solimena M, Singer S, Königsrainer A, Birkenfeld AL, Häring HU, Fritsche A, Ullrich S, Heni M Key Publications
Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort. J Intern Med. 2021;290:1219-1232 June 23, 2022 Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort. J Intern Med. 2021;290:1219-1232 Pammer LM, Lamina C, Schultheiss UT, Kotsis F, Kollerits B, Stockmann H, Lipovsek J, Meiselbach H, Busch M, Eckardt KU, Kronenberg F; GCKD Investigators Key Publications
Inflammation parameters associated with metabolic disorders: relationship between diet and microbiota. Metab Syndr Relat Disord. 2021;19:469-482. June 20, 2022 Inflammation parameters associated with metabolic disorders: relationship between diet and microbiota. Metab Syndr Relat Disord. 2021;19:469-482. Rodríguez-Vera D, Vergara-Castañeda A, Lazcano-Orozco DK, Ramírez-Vélez G, Vivar-Sierra A, Araiza-Macías MJ, Hernández-Contreras JP, Naranjo-Navarro CR, Salazar JR, Loza-Mejía MA, Pinto-Almazán R Key Publications
Insulin resistance, metabolic syndrome, and blood pressure progression among Blacks: the Jackson Heart Study. J Hypertens. 2021;39:2200-2209 June 06, 2022 Insulin resistance, metabolic syndrome, and blood pressure progression among Blacks: the Jackson Heart Study. J Hypertens. 2021;39:2200-2209 Kaze AD, Musani SK, Correa A, Bertoni AG, Golden SH, Abdalla M, Echouffo-Tcheugui JB Key Publications

  of 707 Next page

Go to page: of